Market Research Future

Unnatural Amino Acids Market Comprehensive Analysis and Future Estimations 2023 with Trends and Future Prospects Details for Business Development


Pune, India -- (SBWIRE) -- 06/01/2018 -- Market Scenario

Unnatural amino acids are increasingly growing in research stature for pharmaceuticals, food and feed additives, agrochemicals, and other industrial applications. Some amino acids such as isoleucine, threonine, and hydroxyproline, exhibit second centre of asymmetry and hence can exist in four sterioisomeric forms. The growing importance as pharmaceutical intermediates has led to various methods of enantiomerically pure preparation. Currently the pharmaceutical industry has more than 40 peptides and there are more than 100 in a number of clinical phases. Earlier on the pharmaceutical markets did not have too much interest in peptide research but lately they have developed the interesting peptides which are a result of the modern day latest technological developments, strategic growth, progress in the areas of formulation and improved drug delivery technology of peptides. More and more peptide molecules are now being innovated, and developed by researchers, and studied for their therapeutic properties.

View Reports Sample @

The global unnatural amino acids market is expecting a healthy growth during the forecast period. Unlike the chemical industry, the Pharmaceutical Intermediates industry is influenced by customer requirements and products for specific applications. Major challenging area in the intermediates market is drug development, which is the major driving force. Once the intermediate is developed it has huge potential applications

However, stringent government regulation, and lack of research and development sector in underdeveloped region may hamper the market growth during the forecast period.

The global unnatural amino acids market is expected to grow at a CAGR of 12.44% during the forecast period 2017-2023.

Intended Audience

Pharmaceutical Companies
Research and Development (R&D) Companies
Government Research Institute
Academic Institutes and Universities
Medical Research Laboratories
Market Research and Consulting Service Providers
Potential Investors

The global unnatural amino acids market is segmented on the basis of types, application, and end user.

On the basis the types, it is segmented into D-phenylalanine, D-histidine, D-tyrosine, D-serine, D-alanine, D-tryptophan, D-cysteine, D-phenylglycine, D-p-hydroxy phenylglycine, D-2-chlorophenylglycine, D-penicillamine, D- proline, D-valine, D-citrulline /D-citrulene, D-lysine, D-leucine, D-glutamic acid, D-methionine, D-aspartic acid, D-arginine, D-cycloserine, and others.

On the basis of the application, it is segmented into liver diseases, cancer, inflammatory disease, genetic diseases, and others.

On the basis of end user it is segmented into pharmaceutical & biotechnological companies, research laboratories, academic institutes, and others.

Key Findings

The global unnatural amino acids market is expected to reach USD 3,290.4 million by 2023 at a CAGR of 12.01%
DL-amino acids & derivatives is the second largest segment, which is projected grow at a CAGR of 12.44% during the forecast period from 2017-2023
The Americas captured the largest share of the global market and is expected to reach USD 3,290.4 million by 2023.
Asia Pacific is the fastest growing region across the globe and is expected to grow at a CAGR of 12.16 % during the forecast period.
Regional Analysis

The Americas dominate the global unnatural amino acids market owing to the presence of huge patient population suffering from chronic diseases, changing lifestyle and increasing government support for research & development. Europe accounts for the second largest market for the unnatural amino acids which is followed by Asia Pacific. Government support for the research and presence of huge patient pool has driven the market in Europe region. Asia Pacific is the fastest growing market owing to the huge population base, increasing prevalence of chronic diseases, rapidly developing economies and presence of huge opportunity for the growth of the market. The Middle East & Africa is expected to have limited market but sound growth. Middle East is dominating this market by holding major share of the Middle East & Africa market owing to a well-developed technology and healthcare sector.

Request Full Report @

Key Players

Some of the key players in this market are BASF SE, Sigma-Aldrich Corporation, Novartis AG, Bayer AG, GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.